ViroPharma Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
272.63 Mil |
| Income |
-24.07 Mil |
| Net Profit Margin |
-8.83% |
| Return on Equity |
-3.67% |
| Debt/Equity Ratio |
0.19 |
|
| Revenue/Share |
3.29 |
| Earnings/Share |
-0.33 |
| Book Value/Share |
9.51 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 60.2 | 50.9 | 49.0 |
| 2nd Qtr | 81.9 | 65.4 | 56.1 |
| 3rd Qtr | 80.6 | 65.9 | 50.9 |
| 4th Qtr | NA | 50.0 | 47.7 |
| Total | 222.6 | 232.3 | 203.8 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$0.77 | $0.23 | $0.32 |
| 2nd Qtr | $0.21 | $0.33 | $0.45 |
| 3rd Qtr | $0.26 | $0.39 | $0.30 |
| 4th Qtr | NA | -$0.01 | $0.29 |
| Total | -$0.30 | $0.94 | $1.36 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -7,600% | -21% | --- |
| 2nd Qtr | NA | 43% | 41% |
| 3rd Qtr | 24% | 18% | -33% |
| 4th Qtr | NA | NA | -3% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | NA | -28% |
| 2nd Qtr | -36% | -27% |
| 3rd Qtr | -33% | 30% |
| 4th Qtr | NA | NA |
advertisement
Recent News